Monoclonal antibody 4C5 prevents activation of MMP2 and MMP9 by disrupting their interaction with extracellular HSP90 and inhibits formation of metastatic breast cancer cell deposits
-
* Corresponding author: Evangelia Patsavoudi epatsavoudi@pasteur.gr
1 Department of Biochemistry, Hellenic Pasteur Institute, 127 Vasilissis Sofias Ave., 11521 Athens, Greece
2 Department of Medical Instrumentation, Technological Educational Institution of Athens, Ag. Spyridonos str., Egaleo, 12210 Athens, Greece
BMC Cell Biology 2010, 11:51 doi:10.1186/1471-2121-11-51
Published: 5 July 2010Additional files
Additional file 1:
Additional figure showing that the antibody against HSP90β does not recognize the HSP90α isoform. The western blot analysis of human recombinant HSP90α and total cell lysates (positive control) derived from MDAMB453 cell cultures using anti-HSP90α (positive control) and anti-HSP90β antibodies.
Format: TIFF Size: 448KB Download file
Additional file 2:
Additional figure legend. A file containing the legend of the additional figure.
Format: DOC Size: 25KB Download file
This file can be viewed with: Microsoft Word Viewer
